Viola D, Valerio L, Molinaro E, Agate L, Bottici V, Biagini A, Lorusso L, Cappagli V, Pieruzzi L, Giani C, Sabini E, Passannati P, Puleo L, Matrone A, Pontillo-Contillo B, Battaglia V, Mazzeo S, Vitti P, Elisei R (2016) Treatment of advanced thyroid cancer with targeted therapies: ten years of experience. Endocrine-related Cancer 23:R185–205. https://doi.org/10.1530/erc-15-0555

Article  PubMed  CAS  Google Scholar 

Clark OH (2011) Thyroid cancer and lymph node metastases. J Surg Oncol 103:615–618. https://doi.org/10.1002/jso.21804

Article  PubMed  Google Scholar 

Lam AK (2022) Papillary thyroid carcinoma: current position in Epidemiology, Genomics, and classification. Methods in molecular biology. (Clifton NJ) 2534:1–15. https://doi.org/10.1007/978-1-0716-2505-7_1

Article  CAS  Google Scholar 

Mao JX, Zhang QH, Zhang HY, Zheng K, Wang R, Wang GZ (2020) Risk factors for Lymph Node Metastasis in Papillary thyroid carcinoma: a systematic review and Meta-analysis. Front Endocrinol 11. https://doi.org/10.3389/fendo.2020.00265

Article  Google Scholar 

Pizzimenti C, Fiorentino V, Ieni A, Martini M, Tuccari G, Lentini M, Fadda G (2022) Aggressive variants of follicular cell-derived thyroid carcinoma: an overview. Endocrine 78:1–12. https://doi.org/10.1007/s12020-022-03146-0

Article  PubMed  CAS  Google Scholar 

Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, Pacini F, Randolph GW, Sawka AM, Schlumberger M, Schuff KG, Sherman SI, Sosa JA, Steward DL, Tuttle RM, Wartofsky L (2016) 2015 American Thyroid Association Management Guidelines for adult patients with thyroid nodules and differentiated thyroid Cancer: the American Thyroid Association Guidelines Task Force on thyroid nodules and differentiated thyroid Cancer. Thyroid 26:1–133. https://doi.org/10.1089/thy.2015.0020

Article  PubMed  PubMed Central  Google Scholar 

Coca-Pelaz A, Shah JP, Hernandez-Prera JC, Ghossein RA, Rodrigo JP, Hartl DM, Olsen KD, Shaha AR, Zafereo M, Suarez C, Nixon IJ, Randolph GW, Mäkitie AA, Kowalski LP, Vander Poorten V, Sanabria A, Guntinas-Lichius O, Simo R, Zbären P, Angelos P, Khafif A, Rinaldo A, Ferlito A (2020) Papillary thyroid Cancer-aggressive variants and impact on management: a narrative review. Adv Therapy 37:3112–3128. https://doi.org/10.1007/s12325-020-01391-1

Article  Google Scholar 

Baloch ZW, LiVolsi VA (2018) Special types of thyroid carcinoma. Histopathology 72:40–52. https://doi.org/10.1111/his.13348

Article  PubMed  Google Scholar 

Ohashi R (2020) Solid variant of papillary thyroid carcinoma: an under-recognized entity. Endocr J 67:241–248. https://doi.org/10.1507/endocrj.EJ19-0414

Article  PubMed  CAS  Google Scholar 

Rossi ED, Faquin WC, Pantanowitz L (2019) Cytologic features of aggressive variants of follicular-derived thyroid carcinoma. Cancer Cytopathol 127:432–446. https://doi.org/10.1002/cncy.22136

Article  PubMed  PubMed Central  Google Scholar 

Xie J, Chen P, Wang J, Luo X, Luo J, Xiong X, Li C, Pan L, Wu J, Feng H, Ouyang W (2023) Incorporation size of lymph node metastasis focus and pre-ablation stimulated tg could more effectively predict clinical outcomes in differentiated thyroid cancer patients without distant metastases. Front Endocrinol 14. https://doi.org/10.3389/fendo.2023.1094339

Article  Google Scholar 

Zhu G, Deng Y, Pan L, Ouyang W, Feng H, Wu J, Chen P, Wang J, Chen Y, Luo J (2019) Clinical significance of the BRAFV600E mutation in PTC and its effect on radioiodine therapy. Endocr Connections 8:754–763. https://doi.org/10.1530/ec-19-0045

Article  CAS  Google Scholar 

Marotta V, Sciammarella C, Capasso M, Testori A, Pivonello C, Chiofalo MG, Gambardella C, Grasso M, Antonino A, Annunziata A, Macchia PE, Pivonello R, Santini L, Botti G, Losito S, Pezzullo L, Colao A, Faggiano A (2017) Germline polymorphisms of the VEGF pathway predict recurrence in Nonadvanced differentiated thyroid Cancer. J Clin Endocrinol Metab 102:661–671. https://doi.org/10.1210/jc.2016-2555

Article  PubMed  Google Scholar 

Zhang J, Cheng X, Shen L, Wang X, Wang L, Sun X, Qu S (2020) The Association between Lymph Node Stage and clinical prognosis in thyroid Cancer. Front Endocrinol (Lausanne) 1190. https://doi.org/10.3389/fendo.2020.00090

Wang LY, Ganly I (2016) Nodal metastases in thyroid cancer: prognostic implications and management. Future Oncol (London England) 12:981–994. https://doi.org/10.2217/fon.16.10

Article  CAS  Google Scholar 

Lee J, Song Y, Soh EY (2014) Prognostic significance of the number of metastatic lymph nodes to stratify the risk of recurrence. World J Surg 38:858–862. https://doi.org/10.1007/s00268-013-2345-6

Article  PubMed  Google Scholar 

Adam MA, Pura J, Goffredo P, Dinan MA, Reed SD, Scheri RP, Hyslop T, Roman SA, Sosa JA (2015) Presence and Number of Lymph Node Metastases are Associated with compromised survival for patients younger Than Age 45 years with papillary thyroid Cancer. J Clin Oncology: Official J Am Soc Clin Oncol 33:2370–2375. https://doi.org/10.1200/jco.2014.59.8391

Article  Google Scholar 

Chow SM, Chan JK, Law SC, Tang DL, Ho CM, Cheung WY, Wong IS, Lau WH (2003) Diffuse sclerosing variant of papillary thyroid carcinoma–clinical features and outcome. Eur J Surg Oncology: J Eur Soc Surg Oncol Br Association Surg Oncol 29:446–449. https://doi.org/10.1016/s0748-7983(03)00005-2

Article  Google Scholar 

Crayton H, Wu K, Leong D, Bhimani N, Gild M, Glover A (2023) Diffuse sclerosing variant papillary thyroid carcinoma has worse survival than classic papillary thyroid carcinoma: a meta-analysis. Endocrine-related Cancer 30. https://doi.org/10.1530/erc-22-0348

Ho AS, Luu M, Barrios L, Chen I, Melany M, Ali N, Patio C, Chen Y, Bose S, Fan X, Mallen-St Clair J, Braunstein GD, Sacks WL, Zumsteg ZS (2020) Incidence and mortality risk Spectrum Across aggressive variants of papillary thyroid carcinoma. JAMA Oncol 6:706–713. https://doi.org/10.1001/jamaoncol.2019.6851

Article  PubMed  Google Scholar 

Wang S, Xiong Y, Zhao Q, Song H, Yi P, Liu C (2019) Columnar cell papillary thyroid carcinoma prognosis: findings from the SEER database using propensity score matching analysis. Am J Translational Res 11:6262–6270

Google Scholar 

Ito Y, Miyauchi A, Kihara M, Fukushima M, Higashiyama T, Miya A (2018) Overall survival of papillary thyroid carcinoma patients: a single-Institution Long-Term Follow-Up of 5897 patients. World J Surg 42:615–622. https://doi.org/10.1007/s00268-018-4479-z

Article  PubMed  PubMed Central  Google Scholar 

Ahn D, Heo SJ, Park JH, Kim JH, Sohn JH, Park JY, Park SK, Park J (2011) Clinical relationship between Hashimoto’s thyroiditis and papillary thyroid cancer. Acta Oncol (Stockholm Sweden) 50:1228–1234. https://doi.org/10.3109/0284186x.2011.602109

Article  Google Scholar 

Uhliarova B, Hajtman A (2018) Hashimoto’s thyroiditis– an independent risk factor for papillary carcinoma. Braz J Otorhinolaryngol 84:729–735. https://doi.org/10.1016/j.bjorl.2017.08.012

Article  PubMed  Google Scholar 

Hu X, Wang X, Liang Y, Chen X, Zhou S, Fei W, Yang Y, Que H (2022) Cancer Risk in Hashimoto’s Thyroiditis: a systematic review and Meta-analysis. Front Endocrinol 13. https://doi.org/10.3389/fendo.2022.937871

Xu J, Ding K, Mu L, Huang J, Ye F, Peng Y, Guo C, Ren C (2022) Hashimoto’s Thyroiditis: a double-edged Sword in thyroid carcinoma. Front Endocrinol 13. https://doi.org/10.3389/fendo.2022.801925

Marotta V, Sciammarella C, Chiofalo MG, Gambardella C, Bellevicine C, Grasso M, Conzo G, Docimo G, Botti G, Losito S, Troncone G, De Palma M, Giacomelli L, Pezzullo L, Colao A, Faggiano A (2017) Hashimoto’s thyroiditis predicts outcome in intrathyroidal papillary thyroid cancer. Endocrine-related Cancer 24:485–493. https://doi.org/10.1530/erc-17-0085

Article  PubMed  CAS  Google Scholar 

Ma H, Li L, Li K, Wang T, Zhang Y, Zhang C, Xu Y, Wu X, Yu J, Wang H, Xiang B, Zhang R, Wang W (2018) Hashimoto’s thyroiditis, nodular goiter or follicular adenoma combined with papillary thyroid carcinoma play protective role in patients. Neoplasma 65:436–440. https://doi.org/10.4149/neo_2018_170428N317

Article  PubMed  CAS  Google Scholar 

Mohamed TZ, Sultan AAEA, Tag El-Din M, Mostafa AAE, Nafea MA, Kalmoush A-E, Nassar MS, Abdalgaleel MA, Hegab AM, Ibrahim AH, Baheeg M (2022) Incidence and risk factors of thyroid malignancy in patients with toxic nodular goiter. Int J Surg Oncol 2022:1054297–1054297. https://doi.org/10.1155/2022/1054297

Article  PubMed  PubMed Central  Google Scholar 

Suteau V, Munier M, Briet C, Rodien P (2021) Sex Bias in differentiated thyroid Cancer. Int J Mol Sci 22. https://doi.org/10.3390/ijms222312992

Article  Google Scholar 

Shobab L, Burman KD, Wartofsky L (2022) Sex differences in differentiated thyroid Cancer. Thyroid 32:224–235. https://doi.org/10.1089/thy.2021.0361

Article  PubMed  CAS  Google Scholar 

Remer LF, Lee CI, Picado O, Lew JI (2022) Sex differences in papillary thyroid Cancer. J Surg Res 271:163–170. https://doi.org/10.1016/j.jss.2021.11.004

Article  PubMed  Google Scholar 

Zurnadzhy L, Bogdanova T, Rogounovitch TI, Ito M, Tronko M, Yamashita S, Mitsutake N, Bolgov M, Chernyshov S, Masiuk S, Saenko VA (2022) Clinicopathological implications of the BRAF (V600E) mutation in papillary thyroid carcinoma of Ukrainian patients exposed to the Chernobyl Radiation in Childhood: a study for 30 years after the Accident. Front Med 9:882727. https://doi.org/10.3389/fmed.2022.882727

Article